Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The DMD gene encodes the dystrophin protein, which is crucial for muscle integrity and function. Mutations in this gene lead to Duchenne and Becker muscular dystrophy by disrupting the dystrophin-glycoprotein complex, which normally connects the cytoskeleton to the extracellular matrix in muscle cells.
Exon skipping, which restores a functional dystrophin protein by skipping over mutated exons, thereby allowing the production of a shorter but still functional dystrophin.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dystrophin gene (DMD).